Chem Shift validation: AVS_full, LACS
BMRB Entry DOI: doi:10.13018/BMR19301
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Huang, Wei-Cheng; Ellis, Jacqueline; Moody, Peter; Raven, Emma; Roberts, Gordon. "Redox-linked domain movements in the catalytic cycle of cytochrome p450 reductase." Structure 21, 1581-1589 (2013).
PubMed: 23911089
Assembly members:
CPR, polymer, 614 residues, 70827.4 Da.
FLAVIN MONONUCLEOTIDE, non-polymer, 456.344 Da.
FLAVIN-ADENINE DINUCLEOTIDE, non-polymer, 785.550 Da.
Natural source: Common Name: Human Taxonomy ID: 9606 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Homo sapiens
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: pCS22
Data type | Count |
13C chemical shifts | 523 |
15N chemical shifts | 181 |
1H chemical shifts | 181 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | CPR | 1 |
2 | FMN | 2 |
3 | FAD | 3 |
Entity 1, CPR 614 residues - 70827.4 Da.
This is the cytoplasmic globular domain of a membrane human fibroblast CPR lacking the N-terminal 63 a.a. membrane-anchoring region.
1 | VAL | ARG | GLU | SER | SER | PHE | VAL | GLU | LYS | MET | ||||
2 | LYS | LYS | THR | GLY | ARG | ASN | ILE | ILE | VAL | PHE | ||||
3 | TYR | GLY | SER | GLN | THR | GLY | THR | ALA | GLU | GLU | ||||
4 | PHE | ALA | ASN | ARG | LEU | SER | LYS | ASP | ALA | HIS | ||||
5 | ARG | TYR | GLY | MET | ARG | GLY | MET | SER | ALA | ASP | ||||
6 | PRO | GLU | GLU | TYR | ASP | LEU | ALA | ASP | LEU | SER | ||||
7 | SER | LEU | PRO | GLU | ILE | ASP | ASN | ALA | LEU | VAL | ||||
8 | VAL | PHE | CYS | MET | ALA | THR | TYR | GLY | GLU | GLY | ||||
9 | ASP | PRO | THR | ASP | ASN | ALA | GLN | ASP | PHE | TYR | ||||
10 | ASP | TRP | LEU | GLN | GLU | THR | ASP | VAL | ASP | LEU | ||||
11 | SER | GLY | VAL | LYS | PHE | ALA | VAL | PHE | GLY | LEU | ||||
12 | GLY | ASN | LYS | THR | TYR | GLU | HIS | PHE | ASN | ALA | ||||
13 | MET | GLY | LYS | TYR | VAL | ASP | LYS | ARG | LEU | GLU | ||||
14 | GLN | LEU | GLY | ALA | GLN | ARG | ILE | PHE | GLU | LEU | ||||
15 | GLY | LEU | GLY | ASP | ASP | ASP | GLY | ASN | LEU | GLU | ||||
16 | GLU | ASP | PHE | ILE | THR | TRP | ARG | GLU | GLN | PHE | ||||
17 | TRP | PRO | ALA | VAL | CYS | GLU | HIS | PHE | GLY | VAL | ||||
18 | GLU | ALA | THR | GLY | GLU | GLU | SER | SER | ILE | ARG | ||||
19 | GLN | TYR | GLU | LEU | VAL | VAL | HIS | THR | ASP | ILE | ||||
20 | ASP | ALA | ALA | LYS | VAL | TYR | MET | GLY | GLU | MET | ||||
21 | GLY | ARG | LEU | LYS | SER | TYR | GLU | ASN | GLN | LYS | ||||
22 | PRO | PRO | PHE | ASP | ALA | LYS | ASN | PRO | PHE | LEU | ||||
23 | ALA | ALA | VAL | THR | THR | ASN | ARG | LYS | LEU | ASN | ||||
24 | GLN | GLY | THR | GLU | ARG | HIS | LEU | MET | HIS | LEU | ||||
25 | GLU | LEU | ASP | ILE | SER | ASP | SER | LYS | ILE | ARG | ||||
26 | TYR | GLU | SER | GLY | ASP | HIS | VAL | ALA | VAL | TYR | ||||
27 | PRO | ALA | ASN | ASP | SER | ALA | LEU | VAL | ASN | GLN | ||||
28 | LEU | GLY | LYS | ILE | LEU | GLY | ALA | ASP | LEU | ASP | ||||
29 | VAL | VAL | MET | SER | LEU | ASN | ASN | LEU | ASP | GLU | ||||
30 | GLU | SER | ASN | LYS | LYS | HIS | PRO | PHE | PRO | CYS | ||||
31 | PRO | THR | SER | TYR | ARG | THR | ALA | LEU | THR | TYR | ||||
32 | TYR | LEU | ASP | ILE | THR | ASN | PRO | PRO | ARG | THR | ||||
33 | ASN | VAL | LEU | TYR | GLU | LEU | ALA | GLN | TYR | ALA | ||||
34 | SER | GLU | PRO | SER | GLU | GLN | GLU | LEU | LEU | ARG | ||||
35 | LYS | MET | ALA | SER | SER | SER | GLY | GLU | GLY | LYS | ||||
36 | GLU | LEU | TYR | LEU | SER | TRP | VAL | VAL | GLU | ALA | ||||
37 | ARG | ARG | HIS | ILE | LEU | ALA | ILE | LEU | GLN | ASP | ||||
38 | CYS | PRO | SER | LEU | ARG | PRO | PRO | ILE | ASP | HIS | ||||
39 | LEU | CYS | GLU | LEU | LEU | PRO | ARG | LEU | GLN | ALA | ||||
40 | ARG | TYR | TYR | SER | ILE | ALA | SER | SER | SER | LYS | ||||
41 | VAL | HIS | PRO | ASN | SER | VAL | HIS | ILE | CYS | ALA | ||||
42 | VAL | VAL | VAL | GLU | TYR | GLU | THR | LYS | ALA | GLY | ||||
43 | ARG | ILE | ASN | LYS | GLY | VAL | ALA | THR | ASN | TRP | ||||
44 | LEU | ARG | ALA | LYS | GLU | PRO | ALA | GLY | GLU | ASN | ||||
45 | GLY | GLY | ARG | ALA | LEU | VAL | PRO | MET | PHE | VAL | ||||
46 | ARG | LYS | SER | GLN | PHE | ARG | LEU | PRO | PHE | LYS | ||||
47 | ALA | THR | THR | PRO | VAL | ILE | MET | VAL | GLY | PRO | ||||
48 | GLY | THR | GLY | VAL | ALA | PRO | PHE | ILE | GLY | PHE | ||||
49 | ILE | GLN | GLU | ARG | ALA | TRP | LEU | ARG | GLN | GLN | ||||
50 | GLY | LYS | GLU | VAL | GLY | GLU | THR | LEU | LEU | TYR | ||||
51 | TYR | GLY | CYS | ARG | ARG | SER | ASP | GLU | ASP | TYR | ||||
52 | LEU | TYR | ARG | GLU | GLU | LEU | ALA | GLN | PHE | HIS | ||||
53 | ARG | ASP | GLY | ALA | LEU | THR | GLN | LEU | ASN | VAL | ||||
54 | ALA | PHE | SER | ARG | GLU | GLN | SER | HIS | LYS | VAL | ||||
55 | TYR | VAL | GLN | HIS | LEU | LEU | LYS | GLN | ASP | ARG | ||||
56 | GLU | HIS | LEU | TRP | LYS | LEU | ILE | GLU | GLY | GLY | ||||
57 | ALA | HIS | ILE | TYR | VAL | CYS | GLY | ASP | ALA | ARG | ||||
58 | ASN | MET | ALA | ARG | ASP | VAL | GLN | ASN | THR | PHE | ||||
59 | TYR | ASP | ILE | VAL | ALA | GLU | LEU | GLY | ALA | MET | ||||
60 | GLU | HIS | ALA | GLN | ALA | VAL | ASP | TYR | ILE | LYS | ||||
61 | LYS | LEU | MET | THR | LYS | GLY | ARG | TYR | SER | LEU | ||||
62 | ASP | VAL | TRP | SER |
Entity 2, FMN - C17 H21 N4 O9 P - 456.344 Da.
1 | FMN |
Entity 3, FAD - C27 H33 N9 O15 P2 - 785.550 Da.
1 | FAD |
sample_1: NADPH-Cytochrome P450 reductase, [U-100% 13C; U-100% 15N; U-80% 2H], 0.5 mM; FLAVIN MONONUCLEOTIDE, [U-100% 13C; U-100% 15N; U-80% 2H], 0.5 mM; FLAVIN-ADENINE DINUCLEOTIDE, [U-100% 13C; U-100% 15N; U-80% 2H], 0.5 mM; BES 30 mM; H2O 90%; D2O 10%
sample_conditions_1: ionic strength: 12 mM; pH: 6.5; pressure: 1 atm; temperature: 273 K
Name | Sample | Sample state | Sample conditions |
---|---|---|---|
2D 1H-15N HSQC | sample_1 | isotropic | sample_conditions_1 |
3D 1H-15N TOCSY | sample_1 | isotropic | sample_conditions_1 |
3D HNCA | sample_1 | isotropic | sample_conditions_1 |
3D HNCACB | sample_1 | isotropic | sample_conditions_1 |
3D HNCO | sample_1 | isotropic | sample_conditions_1 |
3D HN(CO)CA | sample_1 | isotropic | sample_conditions_1 |
3D HN(COCA)CB | sample_1 | isotropic | sample_conditions_1 |
3D C(CO)NH | sample_1 | isotropic | sample_conditions_1 |
TOPSPIN v2.1, CCPN - chemical shift assignment, collection, data analysis, processing
UniProt | P16435 |
PDB | |
DBJ | BAB18572 BAD93111 BAE72975 BAF83218 BAG35442 |
EMBL | CAH56151 |
GB | AAB21814 AAD56649 AAF07050 AAF07052 AAF09458 |
REF | NP_000932 NP_001248085 XP_001155755 XP_003276705 XP_003808966 |
SP | P16435 |
AlphaFold | Q9UDT3 P16435 |
Download HSQC peak lists in one of the following formats:
CSV: Backbone
or all simulated peaks
SPARKY: Backbone
or all simulated peaks